Actively Recruiting
Cancer Prevention by Reducing Tobacco With Informatics and Chronic Care Approaches Trial (CONNECT)
Led by Washington University School of Medicine · Updated on 2026-01-08
5000
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating two different strategies to improve tobacco treatment and increase smoking cessation rates among adults receiving care at participating clinics. The study compares a new approach called ELEVATE-S, which adds patient-centered support and self-management tools, against the usual care strategy called ELEVATE, which focuses on supporting clinicians with decision tools. This trial aims to find better ways to help people quit tobacco use and reduce tobacco-related health risks, especially for cancer prevention and control. Participants receive tobacco treatment through two different methods. The ELEVATE group supports clinicians by adjusting professional roles and providing clinical decision support tools to encourage tobacco treatment at the point of care. The ELEVATE-S group includes these clinician supports plus additional patient-focused strategies based on the chronic care model, offering flexible goals and patient-generated health data to help patients manage their tobacco use. During the study, researchers will track how many patients receive tobacco use treatment, including behavioral counseling and medication, and how many successfully stop smoking within six months after enrollment. Study participation involves routine clinical visits, where tobacco use is assessed and treatment is offered through the assigned strategy. The trial will monitor patient outcomes for up to six months to evaluate which approach better increases tobacco treatment and smoking cessation rates.
CONDITIONS
Brief Title
CONNECT Cancer Survivors With Tobacco Treatment
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Be receiving care at a participating clinic
- Report current tobacco use
- Have a completed appointment with a participating clinic
- Be an adult (at least 18 years old)
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 6 months post-enrollment
Participants receive behavioral interventions to support tobacco treatment through clinical decision support and self-management strategies.
Visits as part of routine clinical care
Trial Site Locations
Total: 1 location
1
Washington University School of Medicine
St Louis, Missouri, United States, 63110
Actively Recruiting
Research Team
L
Li-Shiun Chen, M.D., MPH, ScD
N
Nina Smock
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here